Express Healthcare
Home  »  News  »  Wockhardt posts Q4FY18 and FY 17-18 results

Wockhardt posts Q4FY18 and FY 17-18 results

58
Read Article

International business contributed 64 per cent of the total revenues during the Q4FY18

Wockhardt posted its fourth quarter and financial year ended March 31, 2018 results. In Q4-FY18, the company’s net sales is at Rs1,018 crore and in FY 17-18 sales are at Rs 3,937 crore. The business performance during the quarter ended 31st March, 2018 showed marked improvement with sales growth by 18 per cent as compared with the similar quarter of previous year. Emerging Market Business of the company grew by 37 per cent in Q4FY18 over Q4FY17. The UK business in GBP terms grew by 24 per cent in Q4FY18 vs Q4FY17. The company launched three new products in the UK market in FY18. The US business stands at 17 per cent of the global revenues and grew by 13 per cent over last quarter of previous year, mainly on account of new products launches.

International business contributed 64 per cent of the total revenues during the Q4FY18. Research and development expenditure during the quarter was at Rs 77 crore (8 per cent to sales) and including capital expenditure is at 13 per cent to sales. Capital expenditure of Rs 97 crore was incurred during the quarter. The Irish Business grew 6 per cent in INR terms in Q4FY18 vs Q4FY17.

International business contributed 62 per cent of the total revenue. Research and development expenses during FY18 was at Rs 287 crore (7 per cent to sales) and including capital expenditure is at 11 per cent to sales. Capital expenditure of Rs 302 crore was incurred in FY18.

India Business de-grew by 1 per cent in FY18 compared to FY17 mostly on account of GST introduction. 12 new products were launched in FY18. Emerging market business grew by 18 per ent in FY18 compared to FY17. TheUS business stands at 17 per cent of the global revenues. The Irish business grew by 7 per cent in Euro terms in FY18. The company received three new approvals of ANDA during the FY18 and five site transfer approvals during FY 17-18. Total pending ANDAs as on March 31,, 2018 is 70.

Comments are closed.